| Deelneming |
Onderwerp |
| Pepscan |
Pepscan doubles GMP production capacity to facilitate clients’ growth |
| Glycostem |
Glycostem successfully completes funding round |
| Glycostem |
Glycostem signs first 1st commercial agreement for oNKord® and new CAR-NK co-development agreement |
| EggCiting |
Nieuwe website EggCting voor “Host-Milano” |
| Amphera |
Amphera wins top ten list of most groundbreaking innovations in science |
| Amphera |
Amphera recruits first patients to phase II study of MesoPher to treat pancreatic cancer |
| Watermelon |
Chatbotmaker Watermelon na drie jaar weer toegelaten op WhatsApp |
| Glycostem |
Glycostem welcomes Dr Rizwan Romee as US based advisor |
| Lava |
Lava Therapeutics Raises EUR 16 Million to Advance Bispecific Gamma-Delta T Cell Engager Platform. Biologics Expert Paul Parren Joins as Head of R&D. |
| Diagnoptics |
American Heart Association publishes AGE Reader meta-analysis |
